Presolicitation
Atovaquone-Proguanil
Dept of Defense · Defense Logistics Agency · Sol. SPE2D2-23-R-0013
No deadline
AI summary Beta
The Defense Logistics Agency (DLA Troop Support) planned a national requirements contract for atovaquone-proguanil tablets, a malaria medicine, for DoD, VA, Indian Health Service and Bureau of Prisons customers. It would be a one-year base plus four one-year options, open to all sources. This notice was posted in 2023 with a projected solicitation date of September 2023.
Watch out for
- Old notice. Posted in August 2023 with a September 2023 target, so it has likely been solicited and awarded already; check for a current recompete.
The current projected solicitation date is September of 2023.
- Pharmaceutical supply requirements. A drug supplier typically needs FDA-compliant manufacturing or distribution and can face high volume commitments across several federal customers.
to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers
Read from the notice text only.
Full brief
What they want
- Atovaquone-Proguanil 250mg-100mg tablets in 24-count blister pack boxes
- Atovaquone-Proguanil 250mg-100mg tablets in 100-count bottles
- Supply through the DLA and VA prime vendor programs as a national supply source
- Contract type
- Firm-fixed-price requirements contract (FAR 52.216-21), commercial item under FAR Part 12
- Period of performance
- 1 base year + 4 option years
- Contract vehicle
- DLA and VA prime vendor programs; solicitation to be posted on DIBBS and SAM.gov
- How to submit
- Solicitation to be posted on DIBBS (dibbs.bsm.dla.mil) and SAM.gov
What to include when you submit
- Set up automated notifications for pre-solicitation or solicitation changes
- Questions go to Christopher Newman (christopher.newman@dla.mil)
You must have
- Open to all sources; no set-aside
This will be an unrestricted and fully competitive acquisition.
Not in the notice text
- Annual usage estimates (to be in the solicitation's Schedule of Supplies)
- Evaluation method and factors
- Required regulatory approvals or licenses
- Proposal due date
Is this a fit for your business?
Create a free accountFedReady checks notices like this against your business profile, tracks deadlines, and alerts you to new matches. Creating an account is free.
Key facts
- Posted
- Aug 9, 2023
- Notice type
- Presolicitation
- Solicitation
- SPE2D2-23-R-0013
- Agency
- Dept of Defense · Defense Logistics Agency
- Office
- DLA Troop Support
- NAICS
- 325412
- Product/service code
- 6505
- Business type
- Medical & healthcare
- Contracting contact
- Christopher Newmanchristopher.newman@dla.mil2157372905
Full notice text from SAM.gov
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Atovaquone-Proguanil Tablets. Procurement details follow. Atovaquone-Proguanil 250mg-100mg tablets in 24 count blister pack boxes and 100 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Christopher Newman (215-737-2905) (christopher.newman@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2023. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Similar open opportunities
- Latanoprost Ophthalmic Solution (VA-27-00006027)The VA Enterprise Procurement Office plans an unrestricted RFP for Latanoprost eye drops for the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health Care Center.
- Imatinib TabletsThe VA Enterprise Procurement Office plans an unrestricted RFP for Imatinib Mesylate tablets to supply the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health…
- Methylphenidate ERThe Defense Logistics Agency (DLA Troop Support) plans a national requirements contract for Methylphenidate ER tablets (18, 27, 36 and 54 mg, 100-count bottles).
- Epinephrine InjectorThe Defense Logistics Agency (DLA Troop Support) is soliciting a national requirements contract for epinephrine 0.3 mg auto-injectors, to supply Department of Defense, VA, Indian…
- Prednisolone 1% Ophthalmic Solution